Search results
Florian Schönharting. The man behind the BankInvest biotechnology funds for ten years, Schönharting has now moved on to co-found and direct Denmark’s youngest biotech...
Lisa N. Drakeman, Ph.D. had been a vice president at Medarex and wife of Donald Drakeman, Medarex's CEO and President at the time. Drakeman was one of Genmab's co-founders and was appointed chief executive officer (CEO) of the company upon incorporation in 1999, also joining the board of directors. [5]
who survive in the future,” says Florian Schönharting. The man behind the BankInvest biotechnology funds for ten years, Schönharting has now moved on to cofound and direct Denmark’s youngest
Oct 28, 1999 · Moreover, there is ample capital for biotechnology projects“ says Florian SchÖnharting, head of health care and corporate development at BankInvest, one of Medicon Valley's leading venture ...
Nov 14, 2023 · Genmab was founded in the year 1999 Florian Schönharting and Lisa Drakeman. Genmab operates as a biotechnology company and specializes in development of antibody therapeutics for the treatment of cancer.
Jun 12, 2008 · Lisa Drakeman, PhD, was the founding CEO of one of Europe’s most successful biotechnology companies. Under her leadership, the company set numerous financing records, including a record setting IPO, and inaugurated research programs leading to the new FDA-approved medicines DARZALEX (multiple myeloma) and KESIMPTA (multiple sclerosis).
Jun 28, 2021 · While GH Research has been quiet in the press during their IPO period for compliance reasons, Florian Schönharting, Chairman of the Board of Directors of GH Research, said in a press release...
